FDA Investigator Dianne H Milazzo
Dianne H Milazzo has conducted inspections on 359 sites in 3 countries as of 23 Apr 2014. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
359
Last Inspection Date:
23 Apr 2014
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
China,
France
FDA Investigators that have inspected at least one site in common with Dianne H Milazzo:
Abdellah El Hajjam,
Adriana N Jimenez Lopez,
Ali Akbar,
Amanda B Athey,
Amanda M Osteen,
Amber G Chung,
Amber I Jessup,
Amos C Epps,
Amy C Amaro,
Andrew J Howard,
Andrew T Todd,
Anthony M Criscuolo, Jr,
Arindam Dasgupta, PhD,
Ashley M Whitehurst,
Austin B Appler,
Ayorinde O Babalola,
Barbara J Holladay,
Billingsley,
Brandon J Brookens,
Brandon L Mariner,
Brian R Yaun,
Brooke K Higgins,
Brooke K Seeman,
Bruce C Kovak,
Bryan J Love,
Candice C Mandera,
Candice J Cortes,
Carol Rivera Lopez, PhD,
Caroline Strasinger,
Carrie L Doupnik,
Catherine O Lamptey,
Cecil D Mitchell,
Charlean R Butler,
Charles D Boison,
Charles E Idjagboro,
Charlotte E Wilkins,
Christine M O'leary,
Christopher R Richardson,
Chryste D Best,
Clarice J Ahn,
Collins,
Collins M Mason,
Conrad M Guardia,
Craig A Garmendia,
Cynthia A Harris, MD, RN,
David J Leray,
David L Chon,
Decima L Washington,
Dennis L Doupnik,
Dianne T Hamilton,
Dirk L Lincoln,
Douglas A Campbell,
Douglas G Ng,
Dr. Abhijit Raha, PhD,
Dr. Gopa Biswas, PhD,
Dr. Sriram Subramaniam, PhD,
Earl Echon,
Edette J Newby,
Edward P Potter,
Elise A Murphy,
Elizabeth P Mayer,
Elvis D Morton,
Emmanuel A Dimaano, Jr,
Eric L Dong, BS,
Erik T Nagaoka,
Esaw,
Gabriel Davila,
Gale L Glinecki,
Gerald D Bromley, Jr,
Gerald Mierle,
Gifford Whitehurst, Jr,
Heath A Gerber,
Heath R Harley,
Hector Jcolon Torres,
Huixia Zhang,
Iqra Iftikhar,
Jacqueline A O'shaughnessy, PhD,
Jacqueline Johnson,
Jaison J Eapen,
James M Simpson,
James W Leonette,
Jamie D Richardson,
Jamie D Swann,
Jennifer L Barre,
Jessica D Nanini,
Jessica D Weber,
Jingbo Xiao,
Jody E Robinson,
Joell A Eifert,
Joey C West,
John A Kadavil, PhD,
John Dan,
John M Gusto,
Johnson,
Jonathan W Chapman,
Jose R Hernandez,
Julie A Silberberg,
Kailee R Mason,
Karen A Briggs,
Karen S Anthony,
Keith M Reilly,
Kenneth L Smalls,
Kenneth Nieves,
Kirk A Dymbrowski,
Kyle S Hobson,
Laurianne M Montonye,
Lawrence Harmon, Jr,
Lawrence J Stringer,
LCDR Matthew R Mcnew, MPH, REHS/RS,
LCDR Wilfred A Darang,
Lillian C Hsu,
Linda J Eason,
Lisa B Orr,
Lisa M Collins,
Lori S Lawless,
LT Melanie M Mayor, USPHS,
Luella J Rossi,
Luis A Dasta,
Marc A Jackson, Jr,
Marcus A Ray,
Margaret Torres Vazquez,
Marilyn M White,
Marion W Nadeau,
Marla A Cassidy,
Martin K Yau, PhD,
Mary K Leslie,
Melissa J Garcia,
Michael F Skelly, PhD,
Michael L Zimmerman,
Michael O Idowu,
Michael S Call,
Michelle E Noonan Smith,
Mildred L Mccray,
Mohamad A Chahine,
Monique Rac Lester,
Nancy L Meade,
Nash,
Nathaniel R Esaw,
Nebil A Oumer,
Nicholas P Schaub,
Nina D Patel,
Osama M Hamoud,
Paula J Bretz,
Pelekakis,
Philip W Beck,
Pratik S Upadhyay, DDC,
Qin Xu,
Raymond W Niles,
Regina Gibson Melton,
Renisha M Shaw,
Robert P Neligan,
Ruark Lanham,
Sam H Haidar, PhD,
Samuel H Chan, PharmD,
Samuel M Aboagye,
Sara L Sklenka,
Sean R Moynihan, MPH,
Sean Y Kassim, PhD,
Sherry L Secrist, BLT DO,
Sierra M Shockley,
Slatten,
Sonia D Hudson,
Srinivas R Chennamaneni, PhD,
Stephanie A Madison,
Stephanie Mangigian, MS/OSH, RN,
Stephen C Eason,
Susan J Essenmacher,
Suzanne M Healy,
Suzanne M Muchene,
Tamal K Chakraborti, PhD,
Tamara N Champion,
Tammy M Phillips,
Tania E Vizcaino,
Thomas J Hudson,
Thomas R Withers,
Tiki J Dixon,
Walter L Fava,
Wayne L Jefferson,
William A Warnick,
William D Bassett, Jr,
William D Murray,
William H Linkroum,
William P Tonkins,
Xikui Chen (nmi), PhD,
Yih Chain Huang, PhD,
Yiyue Zhang (nmi), PhD,
Zhongren Wu
Dianne H Milazzo's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more